Congenital Syphilis Cases Hit Nearly 4,000 in 2024, Revealing Persistent Gaps in Prenatal Screening and Treatment Access
Rising congenital syphilis reflects missed prenatal screening and treatment amid underfunded public health systems. Evidence from CDC surveillance and state-level interventions points to feasible policy fixes including EHR hard stops and co-located care. Sustained execution and supply-chain reliability are the immediate gaps.
Next steps require CDC-funded performance dashboards tracking time-to-treatment below seven days alongside guaranteed regional penicillin stockpiles. Without these, models project continued growth past 5,000 annual cases by 2027 even if overall syphilis incidence stabilizes.
CDC: Reported congenital syphilis cases will surpass 4,800 nationally by end of 2026 absent new federal Medicaid prenatal presumptive-eligibility rules in at least five high-burden states.
Sources (3)
- [1]CDC Congenital Syphilis Surveillance(https://www.cdc.gov/std/statistics/2022/congenital-syphilis.htm)
- [2]STAT News Opinion on Congenital Syphilis(https://www.statnews.com/2026/06/17/congenital-syphilis-rates-mothers-babies-policy/)
- [3]Texas DSHS Congenital Syphilis Reduction Report(https://www.dshs.texas.gov/hivstd/info/cs/)